Hemofília: nyitott vizsgálatok itt: Olaszország

In Olaszország 23 Also abroad 128

23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.

1/2. fázisToborozTrial-stage medicine
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Where
Milan, Rozzano
Age
2 év to 59 év
People
60 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05987449EU 2023-503906-35-00Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Where
Florence, Milan, Naples, Rome, Rozzano
Age
12 év and over
People
360 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416604EU 2025-522435-33-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Where
Florence, Milan, Naples, Padova
Age
18 év and over
People
84 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07830732EU 2026-525529-19-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Where
Florence, Milan, Padova, Rozzano
Age
1 év to 11 év
People
85 worldwide
Run by
Sanofi
See details and how to joinNCT07285460EU 2025-521858-42-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Where
Genoa, Milan, Parma, Rome, Rozzano, Turin
Age
1 év to 74 év
People
245 worldwide
Run by
Pfizer
See details and how to joinNCT05145127EU 2022-500470-33-00Regiszter frissítve: 2026-10-26
No phaseToborozResearch participation
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
Where
Many Locations
Age
7 év to 12 év
People
40 worldwide
Run by
Bayer
See details and how to joinNCT07088458Regiszter frissítve: 2026-10-26
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Where
Florence, Milan, Naples, Rome, Rozzano
Age
12 év and over
People
138 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416526EU 2025-522434-32-00Regiszter frissítve: 2026-10-26
3. fázisToborozResearch participation
A Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
Where
Napoli
Age
18 év to 64 év
People
32 worldwide
Run by
Pfizer Inc.
See details and how to join2025-523660-21-00EU 2025-523660-21-00Regiszter frissítve: 2026-10-23
1/2. fázisToborozTrial-stage medicine
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Where
Florence, Genoa, Milan, Rome, Rozzano, Vicenza
Age
2 év and over
People
130 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06379789EU 2023-507260-40-00Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Where
Genoa, Parma, Rome, Rozzano, Turin
Age
1 év to 17 év
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05611801EU 2022-500495-65-00Regiszter frissítve: 2026-10-14
No phaseToborozResearch participation
Identification of New Biomarkers in Haemophilic Arthropathy Through Transcriptome Analysis
Where
Milan
People
20
Run by
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07867821Regiszter frissítve: 2026-10-09
No phaseToborozResearch participation
Tight Control of Treatment Adherence and Efficacy by Telemedicine for an Improved Personalized Management of Patients With Hemophilia
Where
Milan
Age
18 év and over
People
50
Run by
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07867834Regiszter frissítve: 2026-10-09
4. fázisToborozTrial-stage medicine
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Where
Milan, Rozzano
Age
12 év and over
People
20 worldwide
Run by
Sanofi
See details and how to joinNCT06145373EU 2022-502414-84-00Regiszter frissítve: 2026-09-23
1. fázisToborozResearch participation
A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
Where
Florence
Age
18 év and over
People
21 worldwide
Run by
Tiumbio Co. Ltd.
See details and how to join2024-511814-20-00EU 2024-511814-20-00Regiszter frissítve: 2026-09-18
1. fázisToborozTrial-stage medicine
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Where
Florence, Naples
Age
18 év to 64 év
People
30 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07220564EU 2025-520490-38-00Regiszter frissítve: 2026-09-18
4. fázisToborozResearch participation
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
Where
Catanzaro, Palermo, Trento
People
17 worldwide
Run by
Octapharma AG
See details and how to join2022-502061-17-00EU 2022-502061-17-00Regiszter frissítve: 2026-07-10
No phaseToborozResearch participation
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Where
Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome, Torino, Turin
People
200 worldwide
Run by
Octapharma
See details and how to joinNCT03695978Regiszter frissítve: 2026-06-02
4. fázisToborozTrial-stage medicine
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Where
Catanzaro, Florence, Milan
Age
12 év and over
People
28 worldwide
Run by
Octapharma
See details and how to joinNCT05935358Regiszter frissítve: 2026-05-12
4. fázisToborozTrial-stage medicine
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Where
Catanzaro, Palermo
Age
12 év and over
People
28 worldwide
Run by
Octapharma
See details and how to joinNCT05936580Regiszter frissítve: 2026-05-12
4. fázisCsak meghívásosResearch participation
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Where
Milan
Age
18 év and over
People
172 worldwide
Run by
BioMarin Pharmaceutical
See details and how to joinNCT05768386EU 2023-507749-27-00Regiszter frissítve: 2026-01-12
No phaseCsak meghívásosResearch participation
A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
Where
Parma, Roma, Torino, Vicenza
People
60 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT04574076Regiszter frissítve: 2025-12-22
4. fázisToborozResearch participation
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
Where
Catanzaro, Florence, Rozzano
People
45 worldwide
Run by
Octapharma AG
See details and how to join2022-502060-21-00EU 2022-502060-21-00Regiszter frissítve: 2025-09-25
No phaseToborozResearch participation
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Where
Florence, Genova, Milan
People
4000 worldwide
Run by
PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119Regiszter frissítve: 2025-09-16

Minden vizsgálat (Hemofília) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek